跳至主要内容
临床试验/CTRI/2026/01/100359
CTRI/2026/01/100359尚未招募3 期

A Randomised controlled trial to compare safety and efficacy of dexmedetomidine versus midazolam continuous infusion for sedation in mechanically ventilated children

Pt. Bhagwat Dayal Sharma post graduate institute of medical sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Sedation is an essential component of care for children requiring invasive mechanical ventilation in the Paediatric Intensive Care Unit (PICU). Adequate sedation improves patient comfort, facilitates ventilator synchrony, and prevents complications such as accidental extubation. Midazolam, a benzodiazepine, is commonly used for sedation but is associated with adverse effects including respiratory depression, tolerance, and withdrawal. Dexmedetomidine, an alpha-2 adrenergic agonist, provides effective sedation with minimal respiratory depression but may cause hemodynamic effects such as bradycardia and hypotension.

This study is designed to compare the efficacy and safety of dexmedetomidine versus midazolam infusion for sedation in mechanically ventilated children admitted to the PICU. It is an open-label randomized controlled trial conducted at a tertiary care teaching hospital. Children aged 1 month to 14 years requiring invasive mechanical ventilation will be enrolled after obtaining written informed consent from parents or legally acceptable representatives.

Eligible participants will be randomized into two groups: one group will receive continuous infusion of dexmedetomidine and the other will receive continuous infusion of midazolam. Sedation will be assessed using the Penn State Children’s Hospital Sedation Algorithm, and drug doses will be titrated to achieve the target sedation level.

The primary outcome is the percentage of time spent in the target sedation range. Secondary outcomes include duration of mechanical ventilation, length of PICU stay, and incidence of adverse effects such as bradycardia, hypotension, and respiratory depression.

The results of this study will help determine the optimal sedative agent for mechanically ventilated children in the PICU and contribute to evidence-based sedation practices in the pediatric critical care setting.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
1.00 Month(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • Children aged 1 month to 14 years on invasive mechanical ventilation in paediatric ICU.

排除标准

  • 1.Children with catecholamine-resistant shock.
  • Children already receiving continuous sedative infusion prior to PICU admission.
  • Children with baseline bradycardia.
  • Children with known atrioventricular conduction abnormalities or heart block.

研究者

发起方
Pt. Bhagwat Dayal Sharma post graduate institute of medical sciences
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

DrVandana Arya

Pt. Bhagwat Dayal Sharma post graduate institute of medical sciences , Rohtak

研究点 (1)

Loading locations...

相似试验